Fundraising Fox
🦊/Companies
Sign in

Vibliome Therapeutics

Bozeman, US · Founded 2017 · Delaware LLC · 1 known investors

Find your way into Vibliome Therapeutics

Founders & leadership

JL
JAMES LINFIELDNamed on SEC filing
GF
GARY FLYNNNamed on SEC filing
RG
ROBERT GOODWINNamed on SEC filing
BS
BRYAN SENDROWSKINamed on SEC filing
CW
CAMERON WHEELERinNamed on SEC filingPartner at Deerfield Management Company
RJ
ROBERT JACKSONNamed on SEC filing
MFMICHAEL FARRELL
MICHAEL FARRELLinNamed on SEC filingHead of Portfolio Company Operations at Deerfield Management Company
JR
JONATHAN RAMOSNamed on SEC filing

Investors · 1

Deerfield Management CompanyreportedNew York

Reported raises · per SEC filings

Form D private placements

$8.1M disclosed across 2 rounds · 2018–2019

▶$8MraisedFeb 2019 · 2 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • ROBERT GOODWINExecutive Officer, Director, Promoter
  • BRYAN SENDROWSKIExecutive Officer
  • GARY FLYNNExecutive Officer, Promoter
  • CAMERON WHEELERDirector
  • ROBERT JACKSONDirector
  • MICHAEL FARRELLExecutive Officer
  • JONATHAN RAMOSExecutive Officer
Offering amount
$16M
Amount sold
$8M
First sale
Feb 2019
Incorporated
Limited Liability Company, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$113KraisedApr 2018 · 3 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES LINFIELDExecutive Officer
  • GARY FLYNNExecutive Officer, Director, Promoter
  • ROBERT GOODWINExecutive Officer, Director, Promoter
Offering amount
$1M
Amount sold
$113K
First sale
Jan 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Vibliome Therapeutics Spins Off New Company, Raises Additional Fundingprnewswire.com · Feb 2022Male Contraception Initiative Awards $500K Research Grant to Vibliome Therapeutics, Inc., for the Development of a New Contraceptive Product | Business Wirebusinesswire.com · Nov 2017

Frequently asked questions

Who are Vibliome Therapeutics's investors?
Vibliome Therapeutics's investors include Deerfield Management Company.
How much funding has Vibliome Therapeutics raised?
Vibliome Therapeutics has disclosed $8.1M raised across 2 rounds.
Where is Vibliome Therapeutics headquartered?
Vibliome Therapeutics is headquartered in Bozeman, US.